These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35045769)
21. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500 [TBL] [Abstract][Full Text] [Related]
22. Update on Persistent Excessive Daytime Sleepiness in OSA. Javaheri S; Javaheri S Chest; 2020 Aug; 158(2):776-786. PubMed ID: 32147246 [TBL] [Abstract][Full Text] [Related]
23. Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment. Weaver TE; Chasens ER; Arora S J Clin Sleep Med; 2009 Dec; 5(6):499-505. PubMed ID: 20465014 [TBL] [Abstract][Full Text] [Related]
24. Recovery Mimicking "Ideal" CPAP Adherence Does Not Improve Wakefulness or Cognition in Chronic Murine Models of OSA: Effect of Wake-Promoting Agents. Badran M; Puech C; Barrow MB; Runion AR; Gozal D Arch Bronconeumol; 2023 Dec; 59(12):805-812. PubMed ID: 37783638 [TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis. Pépin JL; Lehert P; Ben Messaoud R; Joyeux-Faure M; Caussé C; Asin J; Barbé F; Bonsignore MR; Randerath W; Verbraecken J; Craig S; Dauvilliers Y EClinicalMedicine; 2024 Oct; 76():102843. PubMed ID: 39346006 [TBL] [Abstract][Full Text] [Related]
26. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. Keating GM; Raffin MJ CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993 [TBL] [Abstract][Full Text] [Related]
27. On treatment but still sleepy: cause and management of residual sleepiness in obstructive sleep apnea. Launois SH; Tamisier R; Lévy P; Pépin JL Curr Opin Pulm Med; 2013 Nov; 19(6):601-8. PubMed ID: 24060983 [TBL] [Abstract][Full Text] [Related]
28. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials. Wang J; Li X; Yang S; Wang T; Xu Z; Xu J; Gao H; Chen G Pharmacol Res; 2021 May; 167():105522. PubMed ID: 33667687 [TBL] [Abstract][Full Text] [Related]
29. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
30. Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: A comprehensive network meta-analysis and systematic review. Neshat SS; Heidari A; Henriquez-Beltran M; Patel K; Colaco B; Arunthari V; Lee Mateus AY; Cheung J; Labarca G Sleep Med Rev; 2024 Aug; 76():101934. PubMed ID: 38754208 [TBL] [Abstract][Full Text] [Related]
31. Effects of armodafinil on simulated driving and self-report measures in obstructive sleep apnea patients prior to treatment with continuous positive airway pressure. Kay GG; Feldman N J Clin Sleep Med; 2013 May; 9(5):445-54. PubMed ID: 23674935 [TBL] [Abstract][Full Text] [Related]
32. Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP. Bogan RK; Maynard JP; Neuwirth R; Faessel H; Swick T; Olsson T Sleep Med; 2023 Jul; 107():229-235. PubMed ID: 37244138 [TBL] [Abstract][Full Text] [Related]
33. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Abad VC Nat Sci Sleep; 2021; 13():75-91. PubMed ID: 33531850 [TBL] [Abstract][Full Text] [Related]
34. The effect of modafinil following acute CPAP withdrawal: a preliminary study. Williams SC; Rogers NL; Marshall NS; Leung S; Starmer GA; Grunstein RR Sleep Breath; 2008 Nov; 12(4):359-64. PubMed ID: 18311493 [TBL] [Abstract][Full Text] [Related]
35. Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSA. Pépin JL; Attali V; Caussé C; Verbraecken J; Hedner J; Lecomte I; Tamisier R; Lévy P; Lehert P; Dauvilliers Y Chest; 2024 Mar; 165(3):692-703. PubMed ID: 37979718 [TBL] [Abstract][Full Text] [Related]
36. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422 [TBL] [Abstract][Full Text] [Related]
37. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Santamaria J; Iranzo A; Ma Montserrat J; de Pablo J Sleep Med Rev; 2007 Jun; 11(3):195-207. PubMed ID: 17467312 [TBL] [Abstract][Full Text] [Related]
38. [Sleepiness, continuous positive airway pressure and the obstructive sleep apnea hypopnea syndrome]. Lerousseau L Rev Mal Respir; 2018 Feb; 35(2):116-133. PubMed ID: 29454715 [TBL] [Abstract][Full Text] [Related]
39. Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Dinges DF; Weaver TE Sleep Med; 2003 Sep; 4(5):393-402. PubMed ID: 14592280 [TBL] [Abstract][Full Text] [Related]
40. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials. Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]